Who owns 629444950 - NRX PHARMACEUTICALS INC - COM - Put based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

NRX PHARMACEUTICALS INC - COM - Put Institutional Ownership

Q: What is CUSIP 629444950?

CUSIP 629444950 is the security identifier used in SEC filing datasets for 629444950 - NRX PHARMACEUTICALS INC - COM - Put.

CUSIP: 629444950

13F Institutional Holders and Ownership History from Q3 2021 to Q2 2024

Type / Class: Equity / COM

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Investment Quick Answers

What is CUSIP 629444950?
CUSIP 629444950 identifies 629444950 - NRX PHARMACEUTICALS INC - COM - Put in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Continue Investment Research

Latest 13F filings for new institutional portfolio disclosures.
Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
Latest 10-Q/10-K reports to cross-check issuer fundamentals.
Recent insider transactions for management buying/selling context.
SEC investors directory and top value investors for manager-level discovery.
All institutional ownership pages to compare adjacent CUSIP pages.

Recent Quarterly Holder Reports

Open recent reporting periods for CUSIP 629444950:

Q2 2024 (0 holders) Q1 2024 (0 holders) Q3 2023 (0 holders) Q2 2023 (0 holders) Q1 2023 (0 holders) Q4 2022 (0 holders) Q3 2022 (0 holders) Q2 2022 (0 holders) Q1 2022 (0 holders) Q4 2021 (0 holders)

Institutional Holders of NRX PHARMACEUTICALS INC - COM - Put across Reporting Periods

Period	Puts Notional Value	Price (Median)
2024 Q2	$0
2024 Q1	$47	$0.47
2023 Q3	$0
2023 Q2	$3,965	$0.48
2023 Q1	$5,339	$0.66
2022 Q4	$10,435	$1.06
2022 Q3	$6,000	$0.70
2022 Q2	$15,000	$0.59
2022 Q1	$642,000	$2.44
2021 Q4	$1,576,000	$4.78
2021 Q3	$973,000	$467.92